000162628 001__ 162628
000162628 005__ 20240320113535.0
000162628 0247_ $$2doi$$a10.3233/JAD-201238
000162628 0247_ $$2pmid$$apmid:34092629
000162628 0247_ $$2ISSN$$a1387-2877
000162628 0247_ $$2ISSN$$a1875-8908
000162628 0247_ $$2altmetric$$aaltmetric:107154011
000162628 037__ $$aDZNE-2021-01324
000162628 041__ $$aEnglish
000162628 082__ $$a610
000162628 1001_ $$0P:(DE-2719)2811697$$aMelo van Lent, Debora$$b0$$eFirst author$$udzne
000162628 245__ $$aMind Diet Adherence and Cognitive Performance in the Framingham Heart Study.
000162628 260__ $$aAmsterdam$$bIOS Press$$c2021
000162628 3367_ $$2DRIVER$$aarticle
000162628 3367_ $$2DataCite$$aOutput Types/Journal article
000162628 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1710930897_2064
000162628 3367_ $$2BibTeX$$aARTICLE
000162628 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000162628 3367_ $$00$$2EndNote$$aJournal Article
000162628 520__ $$aAdherence to the Mediterranean-DASH for Neurodegenerative Delay (MIND) diet has previously been associated with cognitive decline and dementia. To our knowledge, no prior study has investigated the association between the MIND diet and measures of brain volume, silent brain infarcts (SBIs), or brain atrophy.We evaluated whether adherence to the MIND diet associated with superior cognitive function, larger brain volumes, fewer SBIs, and less cognitive decline in the community-based Framingham Heart Study.2,092 participants (mean±SD, age 61±9) completed Food Frequency Questionnaires, averaged across a maximum of 3-time points (examination cycles 5, 6, and 7), cognitive testing at examination cycle 7 (present study baseline: 1998-2001) and after a mean±SD of 6.6±1.1 years from baseline (n = 1,584). A subset of participants also completed brain magnetic resonance imaging (MRI) at examination cycle 7 (n = 1,904). In addition, participants with dementia, stroke, and other relevant neurological diseases such as significant head trauma, subdural hematoma, or multiple sclerosis were excluded from the analyses.Higher MIND diet scores were associated with better global cognitive function (β±SE,+0.03SD±0.01; p = 0.004), verbal memory, visual memory, processing speed, verbal comprehension/reasoning, and with larger total brain volume (TBV) following adjustments for clinical, lifestyle and demographic covariates, but not with other brain MRI measures (i.e., hippocampal volume, lateral ventricular volume, white matter hyperintensity volume, and SBIs) or cognitive decline.Higher MIND diet scores associated with better cognitive performance and larger TBV at baseline, but not with cognitive decline. Clinical trials are needed to ascertain whether adopting the MIND diet affects trajectories of cognitive decline.
000162628 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000162628 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000162628 650_7 $$2Other$$aApolipoprotein ɛ4
000162628 650_7 $$2Other$$aMIND diet
000162628 650_7 $$2Other$$abrain volume
000162628 650_7 $$2Other$$acognition
000162628 650_7 $$2Other$$adietary pattern
000162628 650_7 $$2Other$$aframingham heart study
000162628 650_7 $$2Other$$asilent brain infarcts
000162628 650_2 $$2MeSH$$aAged
000162628 650_2 $$2MeSH$$aAsymptomatic Diseases
000162628 650_2 $$2MeSH$$aBrain: diagnostic imaging
000162628 650_2 $$2MeSH$$aBrain: pathology
000162628 650_2 $$2MeSH$$aBrain Infarction: diagnosis
000162628 650_2 $$2MeSH$$aBrain Infarction: epidemiology
000162628 650_2 $$2MeSH$$aCognition: physiology
000162628 650_2 $$2MeSH$$aCognitive Dysfunction: epidemiology
000162628 650_2 $$2MeSH$$aCognitive Dysfunction: prevention & control
000162628 650_2 $$2MeSH$$aDiet, Mediterranean: psychology
000162628 650_2 $$2MeSH$$aDiet, Mediterranean: statistics & numerical data
000162628 650_2 $$2MeSH$$aFemale
000162628 650_2 $$2MeSH$$aHumans
000162628 650_2 $$2MeSH$$aLongitudinal Studies
000162628 650_2 $$2MeSH$$aMagnetic Resonance Imaging: methods
000162628 650_2 $$2MeSH$$aMale
000162628 650_2 $$2MeSH$$aMiddle Aged
000162628 650_2 $$2MeSH$$aNeuropsychological Tests
000162628 650_2 $$2MeSH$$aOrgan Size
000162628 650_2 $$2MeSH$$aPatient Compliance: psychology
000162628 650_2 $$2MeSH$$aPatient Compliance: statistics & numerical data
000162628 650_2 $$2MeSH$$aTreatment Outcome
000162628 7001_ $$aO'Donnell, Adrienne$$b1
000162628 7001_ $$aBeiser, Alexa S$$b2
000162628 7001_ $$aVasan, Ramachandran S$$b3
000162628 7001_ $$aDeCarli, Charles S$$b4
000162628 7001_ $$aScarmeas, Nikolaos$$b5
000162628 7001_ $$0P:(DE-2719)2000057$$aWagner, Michael$$b6$$udzne
000162628 7001_ $$aJacques, Paul F$$b7
000162628 7001_ $$aSeshadri, Sudha$$b8
000162628 7001_ $$aHimali, Jayandra J$$b9
000162628 7001_ $$aPase, Matthew P$$b10
000162628 773__ $$0PERI:(DE-600)2070772-1$$a10.3233/JAD-201238$$gVol. 82, no. 2, p. 827 - 839$$n2$$p827 - 839$$tJournal of Alzheimer's disease$$v82$$x1875-8908$$y2021
000162628 8564_ $$uhttps://pub.dzne.de/record/162628/files/DZNE-2021-01324_Restricted.pdf
000162628 8564_ $$uhttps://pub.dzne.de/record/162628/files/DZNE-2021-01324_Restricted.pdf?subformat=pdfa$$xpdfa
000162628 909CO $$ooai:pub.dzne.de:162628$$pVDB
000162628 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811697$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000162628 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000057$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000162628 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000162628 9141_ $$y2021
000162628 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-04
000162628 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-04
000162628 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-04
000162628 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ ALZHEIMERS DIS : 2021$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-18
000162628 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-18
000162628 9201_ $$0I:(DE-2719)1011201$$kAG Wagner$$lNeuropsychology$$x0
000162628 9201_ $$0I:(DE-2719)1011001$$kAG Klockgether$$lPatient Studies$$x1
000162628 980__ $$ajournal
000162628 980__ $$aVDB
000162628 980__ $$aI:(DE-2719)1011201
000162628 980__ $$aI:(DE-2719)1011001
000162628 980__ $$aUNRESTRICTED